Personalized Diet Information for Healthy Habits
(PATTERN Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if personalized diet information can encourage healthier eating choices. Researchers will analyze stool samples using a DNA-based method to provide participants with dietary feedback. The study will assess whether this feedback changes eating habits and improves gut health. Individuals who are primary caregivers for infants under 12 months and can remain in the area for two years may be suitable candidates. The study requires collecting and submitting stool samples from the infant. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could enhance dietary recommendations for better health.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on diet and stool samples, so it's unlikely that your medications will be affected, but it's best to check with the study team.
What prior data suggests that this method is safe for participants?
Research has shown that personalized diet advice is generally safe and easy to follow. This approach provides dietary tips based on individual characteristics, aiming to improve health. Studies have found that customized nutritional advice does not cause significant side effects.
In these studies, participants usually receive personalized feedback about their eating habits, which helps them make healthier choices. This method is considered low risk, with the main concern being the potential loss of privacy from sharing personal dietary information.
Overall, evidence suggests that personalized diet advice is safe for participants. It is designed to help people make better food choices without causing harm.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the potential of using personalized diet information to promote healthy eating habits from an early age. Unlike standard dietary guidance, which is typically generic, this approach uses infants' dietary DNA metabarcoding data from stool samples. This means parents receive nutrition advice that's tailored specifically to their child's unique dietary needs. Such personalized insights could lead to more effective dietary habits, potentially setting a strong foundation for long-term health.
What evidence suggests that personalized diet information is effective for promoting healthy eating habits?
Research has shown that personalized diet advice can help people eat better. For example, one study developed the Infant Diet Quality Index to assess a baby's diet quality from birth to 12 months. It found that a better diet was linked to healthier growth. Additionally, the Dietary Guidelines for Americans are well-known for promoting healthier eating to prevent diseases. Personalized nutrition has shown promise in other studies, especially with infants, where customized plans improved growth and reduced nutrient deficiencies. In this trial, participants in the intervention arm will receive personalized diet information, which could help them make healthier food choices and potentially improve their overall health and well-being.678910
Are You a Good Fit for This Trial?
This trial is for parents or guardians over 18 who understand English, plan to stay local for two years, and care for an infant under 12 months. They must be able to collect and ship their infant's stool samples.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive dietary guidance and their own dietary DNA metabarcoding data from stool samples
Follow-up
Participants are monitored for changes in dietary patterns and gut microbiome composition
What Are the Treatments Tested in This Trial?
Interventions
- Personalized Diet Information
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor